Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Life Sciences
Hardman & Co Healthcare Index
By
Dr Martin Hall
14 Jan 2021
The Monthly: January 2021
12 Jan 2021
Stay up-to-date with the latest research
Sign up to our newsletter
Volta Finance
Financials
Volta’s seven yield uplifts
By
Mark Thomas
11 Jan 2021
Shield Therapeutics Plc
Life Sciences
Reassessing the US opportunity
By
Dr Martin Hall
06 Jan 2021
Neodecortech
Consumer
Upgrade following strong trading
By
Jason Streets
05 Jan 2021
Advanced Oncotherapy
Life Sciences
Leveraging the modularity of LIGHT
By
Dr Martin Hall
15 Dec 2020
BBGI Global Infrastructure
Utilities
Delivering NAV and dividend growth since 2011
By
Nigel Hawkins
14 Dec 2020
Arbuthnot Banking Group Plc
Financials
Acquisition of Asset Alliance
By
Mark Thomas
11 Dec 2020
Incanthera Ltd
Life Sciences
Solid progress since listing
By
Dr Martin Hall
08 Dec 2020
Arix Bioscience
Life Sciences
Artios attracts Merck KGaA in deal up to $7bn
By
Dr Martin Hall
07 Dec 2020
Oakley Capital Investments
Financials
NAV: conservative, robust and with growth upside
By
Mark Thomas
03 Dec 2020
Prev
1
2
3
4
5
6
...
49
Next
